Long-term effectiveness and safety of dupilumab treatment in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the BioDay registry
Marie Louise A. Schuttelaar, Celeste M. Boesjes, Junfen Zhang, Laura Loman, Esmé Kamphuis, Lian F. van der Gang, Lisa P. van der Rijst, Lotte S. Spekhorst, C. Dekkers, Geertruida L. E. Romeijn, N. Peter A. Zuithoff, Inge Haeck, Marijke Kamsteeg, A. J. Oosting, Antoni Gostynski, A. M. T. van Lynden-van Nes, Ron A. Tupker, A. van Tuyll van Serooskerken, A. Flinterman, Klaziena PolitiekW. R. H. Touwslager, Wianda A. Christoffers, S. M. Stewart, Marlies de Graaf, M. S. de Bruin-Weller
Research output: Contribution to journal › Meeting Abstract › Academic
Fingerprint
Dive into the research topics of 'Long-term effectiveness and safety of dupilumab treatment in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the BioDay registry'. Together they form a unique fingerprint.